![Richard Hoffman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Hoffman
Algemeen Adviseur bij
INCYTE CORPORATION
Vermogen: 1 M $ op 30-06-2026
Profiel
Richard A. Hoffman was the founder of TargetRx, Inc., founded in 1999, where the title held was Chief Executive Officer.
Mr. Hoffman currently works at Incyte Corp.
as Secretary, Executive VP & General Counsel since 2025.
Former jobs include Chief Executive Officer at Synglyco, Inc., Chief Business Officer at Ablexis LLC, and Partner at Goodwin Procter LLP.
Education history includes graduate degrees from The Trustees of Columbia University in The City of New York and Columbia Law School, an MBA from The Wharton School of the University of Pennsylvania, and an undergraduate degree from Harvard College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-12-2025 | 9.466 ( 0% ) | 1 M $ | 30-06-2026 |
Actieve functies van Richard Hoffman
| Bedrijven | Functie | Begin |
|---|---|---|
| INCYTE CORPORATION | Algemeen Adviseur | 01-12-2025 |
Eerdere bekende functies van Richard Hoffman
| Bedrijven | Functie | Einde |
|---|---|---|
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
Ablexis LLC
 Ablexis LLC Packaged SoftwareTechnology Services Develops next-generation platform for antibody drug discovery | Corporate Officer/Principal | - |
Synglyco, Inc.
 Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Algemeen Directeur | - |
TargetRx, Inc.
 TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing consultancy services | Algemeen Directeur | - |
Opleiding van Richard Hoffman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
23
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
TargetRx, Inc.
TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing consultancy services | Commercial Services |
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Ablexis LLC
Ablexis LLC Packaged SoftwareTechnology Services Develops next-generation platform for antibody drug discovery | Technology Services |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
